Related Experiment Videos
Second-generation antipsychotics in the emergency care setting. A prospective naturalistic study
1Servizio Psichiatrico di Diagnosi e Cura, Ospedale Santo Spirito in Sassia, Rome, Italy.
General Hospital Psychiatry
|May 24, 2000
Summary
Switching to atypical antipsychotics in psychiatric units did not increase violence or hospitalization length. These newer drugs are effective and safer, making them ideal for first-line treatment of psychosis.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Standard neuroleptics were traditionally used for psychotic disorders.
- Atypical antipsychotic agents offer a potentially improved side-effect profile.
Purpose of the Study:
- To evaluate the impact of replacing standard neuroleptics with atypical antipsychotics in an intensive psychiatric care unit.
- To compare patient outcomes before and after the implementation of atypical antipsychotics as first-line treatment.
Main Methods:
- A mirror-image study design was employed.
- Patient data from two distinct periods were compared: one using standard neuroleptics and another using atypical antipsychotics.
- Outcomes assessed included medication dosages, length of hospitalization, and rates of aggressive behavior.
Main Results:
- Patients treated with atypical antipsychotics received lower dosages of antipsychotics and fewer anticholinergics.
- There were no significant differences in hospitalization length, transfer rates, or rates of aggressive/violent behavior between the two groups.
- Increased use of anticonvulsants like valproate and gabapentin was observed with atypical antipsychotic use.
Conclusions:
- The transition to atypical antipsychotics in intensive psychiatric care is safe and effective.
- Risks of increased violence, prolonged hospitalization, or non-compliance are not significant concerns with second-generation antipsychotics.
- Atypical antipsychotics should be considered first-line treatment for psychotic disorders due to their efficacy and favorable side-effect profile.